重要内容提示： | 证券代码：688352 | 证券简称：颀中科技 | 公告编号：2026-018 | | --- | --- | --- | | 转债代码：118059 | 转债简称：颀中转债 | | 合肥颀中科技股份有限公司 关于可转债投资者适当性要求的风险提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 1 债券简称"颀中转债"，债券代码"118059"。 （三）可转债转股期限 根据相关法律法规规定及《合肥颀中科技股份有限公司向不特定对象发行 可转换公司债券募集说明书》（以下简称"《募集说明书》"）的约定，合肥颀 中科技股份有限公司（以下简称"公司"）本次发行的"颀中转债"自2026年5月 7日起可转换为公司股份。 公司现就本次向不特定对象发行可转换公司债券，对不符合上海证券交易 所科创板股票投资者适当性要求的投资者所持"颀中转债"不能转股的风险，提 示如下： 一、可转换公司债券发行上市概况 （一）可转债发行情况 经中国证券监督管理委员会《关于同意合肥颀中科技股份有限公司向不特定 对象发行可转换公司债券注册 ...

关于合肥颀中科技股份有限公司 增加 2026 年度日常关联交易预计情况的核查意见 中信建投证券股份有限公司（以下简称"中信建投"、"保荐人"）作为合 肥颀中科技股份有限公司（以下简称"颀中科技"或"公司"）首次公开发行股 票并在科创板上市的保荐人及持续督导机构，根据《证券发行上市保荐业务管理 办法》《上海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司 自律监管指引第 1 号——规范运作》等有关规定，对颀中科技增加 2026 年度日 常关联交易预计情况进行了审慎核查，核查情况及核查意见如下： 一、日常关联交易的基本情况 （一）日常关联交易履行的审议程序 2026 年 3 月 19 日，公司召开第二届独立董事第八次专门会议审议通过了《关 于增加 2026 年度日常关联交易预计情况的议案》。全体独立董事认为：公司本次 增加 2026 年度日常关联交易预计情况系因应公司全资子公司颀中科技（苏州） 有限公司于 2026 年 1 月 24 日凸块制程生产区域发生火灾事故，部分无尘室生产 环境受损、相关生产设备出现故障，导致凸块制程部分工序的生产能力暂时受限， 为最大程度降低突发事故对公司生产经营的不利影响， ...

中信建投证券股份有限公司 关于合肥颀中科技股份有限公司 拟受让基金份额暨关联交易的核查意见 中信建投证券股份有限公司（以下简称"中信建投"、"保荐人"）作为合肥颀 中科技股份有限公司（以下简称"颀中科技"或"公司"）首次公开发行股票并在科 创板上市的保荐人及持续督导机构，根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上海证券交易所科创板上市公司自律监管 指引第 1 号——规范运作》等有关规定，对颀中科技拟受让基金份额暨关联交易 事项进行了审慎核查，核查情况及核查意见如下： 一、关联交易概述 （一）本次交易概况 为推动公司战略布局，把握战略合作机会，拓展集成电路先进封装测试领域 的业务协同，公司拟以零对价分别受让合肥科融高科技产业投资有限公司（以下 简称"科融高科"）持有的合肥建汇战新股权投资基金合伙企业（有限合伙）（以 下简称"建汇合伙"）未实缴 9,900 万元基金份额对应的认缴权及合肥市滨湖新 区建设投资有限公司（以下简称"滨湖新区建设"）持有的建汇合伙未实缴 8,000 万元基金份额对应的认缴权，总计受让 17,900 万元基金份额，占基金总认缴出 资额的比例为 5.849 ...

| 证券代码：688352 | 证券简称：颀中科技 | 公告编号：2026-016 | | --- | --- | --- | | 转债代码：118059 | 转债简称：颀中转债 | | 合肥颀中科技股份有限公司 关于增加 2026 年度日常关联交易预计情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 同日，公司召开第二届董事会第九次会议，审议通过了《关于增加2026年 度日常关联交易预计情况的议案》。关联董事罗世蔚先生回避了本次表决，其 他非关联董事一致同意前述议案。 本次公司增加2026年度日常关联交易预计事项尚需提交公司股东会审议， 与该关联交易有利害关系的关联人将放弃行使在股东会上对该议案的投票权。 （二）本次关联交易预计增加的情况 ● 本次关联交易尚需提交合肥颀中科技股份有限公司（以下简称"公司"） 股东会审议。 ● 日常关联交易对公司的影响：本次关联交易为日常关联交易，属于正 常生产经营业务的范畴，以市场价格为定价依据，遵循平等自愿原则，交易风 险可控，不存在损害公司及股东利益的情况。 ...

| 证券代码：688352 | 证券简称：颀中科技 | 公告编号：2026-017 | | --- | --- | --- | | 转债代码：118059 | 转债简称：颀中转债 | | 合肥颀中科技股份有限公司 关于拟受让基金份额暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资基金名称及投资方向，与上市公司主营业务相关性：合肥建汇战 新股权投资基金合伙企业（有限合伙）（以下简称"建汇合伙"）是合肥市国有 资本战新产业投资基金，将重点投资集成电路、新型显示等领域，与公司主 营业务具有相关性。 相关风险提示： 1、截至本公告日，本次交易的相关协议尚未签署，尚需有关部门批准，具 体内容以实际签署的协议为准，交易实施存在不确定性风险。敬请广大投资者谨 慎决策，注意投资风险。 2、投资私募基金具有投资周期长、流动性较低等特点，公司作为基金的有 限合伙人承担的风险敞口以投资额为限，本次投资无保本及最低收益的承诺。本 次投资完成后，公司将加强与合作方的沟通，及时跟进基金运作与投资项目的实 施情况，督促 ...

Core Insights - Bumping technology is a critical foundational process in advanced packaging types such as FC, 2.5D/3D, and WLP, extending from the front-end wafer manufacturing stage [1] - According to TrendBank, the demand for advanced packaging wafers in mainland China has reached 19 million pieces annually, accounting for 40% of the market share (equivalent to 12-inch wafers) [1] - The Yangtze River Delta region, which includes Shanghai, Anhui, Jiangsu, and Zhejiang, leads the nation with 51% of the advanced wafer bump manufacturing capacity [1] Company Insights - In the FC Bump segment, Qizhong Technology ranks first in China, focusing on specialty packaging for display chip flip-chip packaging [1] - For WLP Bump, Shenghe Jingwei holds the top position domestically, operating in a general comprehensive packaging sector that targets consumer electronics, telecommunications, and data center applications [1] - In the 2.5D/3D Bump category, Shenghe Jingwei also leads the market in China [1]

| 证券代码：688352 | 证券简称：颀中科技 | 公告编号：2026-015 | | --- | --- | --- | | 转债代码：118059 | 转债简称：颀中转债 | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 回购方案首次披露日 | 2025/6/19 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 回购方案实施期限 | 2025 年 6 月 6 | 18 | 日~2026 | 年 | 月 | 17 | 日 | | 预计回购金额 | 7,500万元~15,000万元 | | | | | | | | 回购用途 | □减少注册资本 √用于员工持股计划或股权激励 | | | | | | | | | □用于转换公司可转债 □为维护公司价值及股东权益 | | | | | | | | 累计已回购股数 | 8,714,483股 | | | | | | | | 累计已回购股数占总股本比例 | 0.73% | | | ...

Group 1: Key Insights on Convertible Bonds - The report highlights the top ten convertible bonds for March, including companies like Meinuohua, Tai Rui Machinery, and Jiangsu Huachen, each with unique growth drivers and market positions [2][10][21]. - The overall market sentiment is positive, with expectations of a "spring rally" driven by increased investment in technology and high-end manufacturing sectors [3][55]. - The report notes that the convertible bond market is experiencing a relative valuation high, with a decrease in median prices across various parity ranges, indicating potential investment opportunities [2][55]. Group 2: Company-Specific Insights - Meinuohua is advancing its innovative pipeline, particularly the JH389 project, which is expected to enhance its market position in the pharmaceutical sector [10]. - Tai Rui Machinery is recognized as a leading manufacturer of injection molding machines, focusing on high-end markets to compete with international players [33][34]. - Jiangsu Huachen is positioned to benefit from the global shift towards renewable energy, with a strategic focus on expanding its overseas market presence [21][22]. - Youfa Group, as the largest manufacturer of welded steel pipes in China, is leveraging its competitive advantages to navigate the upcoming supply-side reforms [19][20]. - Yubang New Materials is actively developing products for the energy storage and data center markets, anticipating significant growth in these sectors [43][44]. - Ruikeda is expanding its product offerings in the electric vehicle and data center markets, capitalizing on the growing demand for high-speed connectors [48][49]. - Hongya CNC is a leader in the furniture equipment sector, providing comprehensive automation solutions to enhance production efficiency [25][26]. - Qizhong Technology specializes in advanced packaging and testing services for integrated circuits, maintaining a competitive edge in the semiconductor industry [29][30]. - The report emphasizes the importance of monitoring the evolving market dynamics and technological advancements across these sectors to identify potential investment opportunities [3][56].

（编辑 王雪儿） 证券日报网讯 2月26日，颀中科技发布2025年度业绩快报公告称，2025年度公司实现营业总收入 219026.12万元，同比增长11.78%；归属于母公司所有者的净利润26579.08万元，同比下降15.16%。 ...

Group 1 - Hehe Information achieved operating revenue of 1.81 billion yuan in 2025, a year-on-year increase of 25.83%, and net profit of 454 million yuan, a year-on-year increase of 13.39% [1] - Shengyi Technology announced that Guangxin Group and Chen Renxi have completed their share reduction plan, with Guangxin Group reducing its shares by 24.29 million, accounting for 1% of the total share capital [2] - Huaci Co., Ltd. received approval from the China Securities Regulatory Commission for its stock issuance to specific targets [3] Group 2 - New Nuo Wei plans to transfer 30.07% of its shares in Guoxin Huijin to Shiyao Holdings for 230 million yuan, with a valuation increase of 94.85% [4] - Tianli Lithium Energy has completed the scheduled maintenance of its lithium iron phosphate production line and resumed production [5] - Jinchuan Electric reported a net profit of 81.218 million yuan in 2025, a year-on-year decrease of 10.87% [6] Group 3 - Shenzhou Taiyue reported a net profit of 798 million yuan in 2025, a year-on-year decrease of 44.09% [7] - Jingwei Hengrun achieved a net profit of 99.5375 million yuan in 2025, reversing a loss from the previous year [8] - Keheng Technology signed a maximum pledge contract worth 450 million yuan to support its supply chain procurement [9] Group 4 - Zhongchu Media reported a net loss of 20.2858 million yuan in 2025, with operating revenue of 157 million yuan, a year-on-year decrease of 18.99% [10] - Tongde Chemical's subsidiary is involved in a lawsuit with a claim amount of approximately 49.1824 million yuan [12] - Jichuan Pharmaceutical signed an exclusive commercialization rights agreement for a new eczema treatment, with payments not exceeding 190 million yuan [13] Group 5 - Tianli Lithium Energy reported a net loss of 211 million yuan in 2025, with operating revenue of 408 million yuan, a year-on-year decrease of 20.20% [14] - Fortune Trend achieved a net profit of 315 million yuan in 2025, a year-on-year increase of 3.62% [15] - CITIC Securities received approval to publicly issue corporate bonds totaling no more than 80 billion yuan [16] Group 6 - Yongshan Lithium Industry reported a reduction of 23 million shares by Ningbo Jutai, decreasing its total shareholding from 13.24% to 4.52% [17] - Taifu Pump Industry achieved a net profit of 17.5631 million yuan in 2025, a year-on-year increase of 38.78% [18] - Longxun Co., Ltd. reported a net profit of 172 million yuan in 2025, a year-on-year increase of 19.05% [19] Group 7 - Duori Pharmaceutical's acquisition offer period has expired, and the company's stock will resume trading [20] - Tianhao Energy obtained a loan commitment letter for stock repurchase from a financial institution, with a loan amount not exceeding 90 million yuan [21] - Lijun Co., Ltd. reported a net profit of 57.545 million yuan in 2025, a year-on-year decrease of 52.09% [22] Group 8 - Zhongchumai reported a net profit of 212 million yuan in 2025, a year-on-year increase of 45.55% [23] - Kangxino reported a net profit of 27.8727 million yuan in 2025, reversing a loss from the previous year [24] - Baiao Saitu achieved a net profit of 173 million yuan in 2025, a year-on-year increase of 416.37% [25] Group 9 - Guangxun Technology's private placement application was approved by the Shenzhen Stock Exchange [26] - Sandam Membrane reported a net profit of 378 million yuan in 2025, a year-on-year increase of 19.95% [27] - Shangsheng Electronics reported a net profit of 184 million yuan in 2025, a year-on-year decrease of 21.71% [28] Group 10 - Xin'an Century reported a net profit of 79.2904 million yuan in 2025, reversing a loss from the previous year [29] - Zhenlei Technology achieved a net profit of 133 million yuan in 2025, a year-on-year increase of 582.01% [30] - Fuan Pharmaceutical's subsidiary received approval for a new drug application [32] Group 11 - Baotai reported a net loss of 336 million yuan in 2025, with operating revenue of 934 million yuan [33] - Aohua Endoscope reported a net profit of 11.4619 million yuan in 2025, a year-on-year decrease of 45.45% [34] - Maide Medical reported a net profit of 65.2599 million yuan in 2025, reversing a loss from the previous year [35] Group 12 - Chip Original Co. reported a net loss of 528 million yuan in 2025, with operating revenue of 3.152 billion yuan [36] - Zhongwei Semiconductor set a preliminary transfer price of 43.35 yuan per share for its inquiry [37] - Tieke Railway reported a net profit of 171 million yuan in 2025, a year-on-year decrease of 20.09% [38] Group 13 - Changjiang Electric announced a cash dividend distribution plan of 2.1 yuan per 10 shares for the 2025 fiscal year [39] - Kunheng Shunwei reported a net profit of 46.7676 million yuan in 2025, a year-on-year increase of 26.28% [40] - Ailis reported a net profit of 2.181 billion yuan in 2025, a year-on-year increase of 52.55% [41] Group 14 - Aerospace Software reported a net loss of 11.3126 million yuan in 2025, with operating revenue of 1.216 billion yuan [42] - Qizhong Technology reported a net profit of 266 million yuan in 2025, a year-on-year decrease of 15.16% [43] - Guotou Zhonglu plans to acquire 70% of Luochuan Lingxian Company for 74.8745 million yuan [44] Group 15 - Aokema plans to acquire 45% of its subsidiary for 253 million yuan [45] - ST Dali signed a procurement framework agreement worth 88.8794 million yuan with a leading new energy company [46] - Zhifei Biological received clinical trial approval for a new mRNA vaccine [47]